FDA Investigator Denarvis C Mendenhall
Denarvis C Mendenhall has conducted inspections on 37 sites in 1 countries as of 31 Oct 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
31 Oct 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Denarvis C Mendenhall:
Adam J Taylor,
Alicia M Mozzachio,
Amina Bashir,
Antoinette L Chancey,
Ashley L Reiber,
Audrey Dela Cruz,
Brentley S Collins,
Brian D Nicholson,
Brian P Emanuel,
Brittani N Franklin,
Brittany R Laymon,
Bruce H Mccullough,
Bryan L Mcguckin,
Carl A Huffman, III,
Carrie Ann Plucinski,
Chad E Schmear,
Chase S Baldwin,
Christina A Miller,
Christopher D Leach,
Clotia Cabbey Mensah,
Constantin Y Philopoulos,
Daniel B Arrecis,
Dariusz Galezowski,
Darrell E Luedtke,
Debra I Love,
Emilie E Kahn,
Enrico Joset Mangahis,
Eric M Mueller, PharmD,
Gregory R Dill,
James P Duggan,
James W Plucinski,
Jason F Chancey,
Jeanne J Chiu,
Jeanne J Thai,
Jeanne M Morris,
Jennifer C Johnson,
Jesse A Vazquez,
Jocelyn C Turner,
John M Seale,
Joseph D Cooper,
Joshua M Adams,
Karen Emasley Joseph,
Kathleen S Tormey,
Larry F Hallberg,
Latoya A Griffith,
Lauren A Crivellone,
Lee Terry Moore,
Lequita M Mayhew,
Lindsey S Fleischman,
Lisa Hayka,
Lisa Hornback,
Maksim A Levenchuk,
Maria Diaz,
Mark I Kaspar,
Matthew T Sanchez,
Michael D Robinson,
Michael E Maselli,
Michael Y Philopoulos,
Michele L Glendenning,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole S Williams,
Norman K Starks,
Norman L Brown,
Pablo Alcantara,
Patrick E Gainer,
Paula P Demichael,
Peng Zhou,
Phung Thien Nguyen,
Roberta W Cunningham,
Rosemary Wood Sexton,
Russell K Riley,
Ryan Gibson,
Stephanie A Wright,
Stephen D Eich,
Sullan,
Susan P Bruederle,
Susan W Ciani,
Tara C Alcazar,
That Q Dang,
Thomas W Nojek,
Timothy Brennan,
Todd M Stankewicz,
Uruaku A Obasi,
Vaishali J Patel,
Vioela J Caze,
William D Sherman,
William G Nelson,
William R Weissinger
Denarvis C Mendenhall's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2010 | EIR | Corn Products International, Inc. - EIR, 2010-09-24 |
November, 2011 | FDA 483 | Sage Products LLC - Form 483, 2011-11-09 |
March, 2011 | FDA 483 | Regis Technologies Inc. - Form 483, 2011-03-08 |
August, 2011 | FDA 483 | H2O Plus, LLC - Form 483, 2011-08-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more